U.S. to pay $2.1 billion to Sanofi, GSK, in COVID-19 vaccine deal
The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID19 vaccines to cover 50 million people and to underwrite the drug makers' testing and manufacturing, the companies said on Friday.